troglitazone has been researched along with Allergic Encephalomyelitis in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niino, M | 1 |
| Iwabuchi, K | 1 |
| Kikuchi, S | 1 |
| Ato, M | 1 |
| Morohashi, T | 1 |
| Ogata, A | 1 |
| Tashiro, K | 1 |
| Onoé, K | 1 |
1 other study available for troglitazone and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma.
Topics: Animals; Cell Division; Chromans; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; In | 2001 |